Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression

Baldessarini, Ross J., Lau, Wai Keat, Sim, Jordan, Sum, Min Yi, Sim, Kang · 2015 · Journal of Clinical Psychopharmacology

Abstract

BACKGROUND: The efficacy, limitations, and methods of studying antidepressant treatment continued beyond initial weeks of acute major depression remain incompletely resolved. AIMS: For subjects treated in controlled trials for acute depression, we analyzed the relationship of relapse risk within 12 months of rerandomizing to placebo versus duration of initial treatment and putative stabilization. METHODS: With data from placebo arms of 45 relevant controlled trials identified in recent, systematic reviews were pooled and analyzed by regression modeling. RESULTS: There was a strong inverse correlation of shorter initial treatment and greater relapse risk after rerandomizing to placebo treatment, best fit to a power function (P ≤ 0.003); relapse risk differed by 11.4-fold, declining sharply as initial treatment continued for 16 to 20 weeks or more. CONCLUSIONS: Discontinuation of antidepressant treatment for major depressive episodes at times less than 6 months was associated with rising risks after randomization to continuation with placebo. This relationship requires critical consideration in both clinical management of depressed patients and the design and interpretation of treatment discontinuation trials.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0000000000000263

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 7 references

Research works printed but not linked: 1

  1. Borges, 2014, Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration, J Clin Psychiatry., 75, 205

Cited by

See all 52

Metadata

Authors
Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y., & Sim, K.
Affiliations
  • Harvard University (US)
  • National University of Singapore (SG)
  • Institute of Mental Health (SG)
Corresponding author
Baldessarini, Ross J.
Venue
Journal of Clinical Psychopharmacology
Published
2015-02
Volume
35
Issue
1
Pages
75-76
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2317076828
Cited by
52
References
7
Citations by year
2025: 1 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 1
FWCI
2.67
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
major depressive disorder, antidepressant treatment duration, relapse risk, treatment discontinuation, placebo response, power function relationship
MeSH terms
Antidepressive Agents, Major Depressive Disorder, Drug Administration Schedule, Female, Humans, Male, Recurrence, Randomized Controlled Trials as Topic, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression. https://app.cochat.ai/papers/10.1097/jcp.0000000000000263
The paper
Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y., & Sim, K. (2015). Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000263

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.